Search
for
Sort by
Research 421–450 of 1000+
- Polycystic ovary syndrome: A review for dermatologists
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- What does acne genetics teach us about disease pathogenesis?
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Recent advances in the treatment of psoriasis
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- How to Diagnose Hair Loss
- Idiopathic CD4+ T-lymphocytopenia
- Alopecia in Association with Malignancy: A Review
- Alterations in Hair Follicle Dynamics in Women
- Congenital adrenal hyperplasia
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Adverse health effects of androgen use
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Thyroid hormone action on skin.
- Clinical markers of androgenicity in acne vulgaris
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women
- Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- PTCH1 Germline Mutations and the Basaloid Follicular Hamartoma Values in the Tumor Spectrum of Basal Cell Carcinoma Syndrome (NBCCS)
- Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Evaluation of hair loss
- Secondary cicatricial and other permanent alopecias
- Alopecia Possibly Secondary to Topical Ophthalmic β-Blockers